BayBridge Capital Group’s Johnson & Johnson JNJ Stock Holding History

BayBridge Capital Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	6,348 -23	-0.4%	-$5.36K	0.84%	34
2026 Q1	$1.32M	Hold	6,371	–	–	0.82%	42
2025 Q4	$1.32M	Buy	6,371 +168	+3%	+$33.2K	0.82%	42
2025 Q3	$1.15M	Buy	+6,203	New	+$1.06M	0.73%	43
2024 Q4	–	Sell	-2,107	Closed	-$341K	–	98
2024 Q3	$341K	Sell	2,107 -5,336	-72%	-$850K	0.25%	84
2024 Q2	$1.09M	Buy	7,443 +247	+3%	+$36.7K	0.85%	42
2024 Q1	$1.07M	Buy	+7,196	New	+$1.15M	0.93%	38

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BayBridge Capital Group's JNJ Position: Q2 2026 in Review

BayBridge Capital Group reduced its Johnson & Johnson (JNJ) stake by 0.36% in Q2 2026, selling an estimated $5.36K and leaving 6,348 shares worth $1.61M. The position accounts for 0.84% of the portfolio, ranked #34.

BayBridge Capital Group first reported a position in JNJ in Q1 2024 and has held it in 7 quarters since. 2,221 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

BayBridge Capital Group held 6,348 shares of Johnson & Johnson worth $1.61M as of Q2 2026.
BayBridge Capital Group sold 23 Johnson & Johnson shares in Q2 2026, an estimated $5.36K.
Johnson & Johnson made up 0.84% of BayBridge Capital Group's portfolio in Q2 2026, its #34 holding.
BayBridge Capital Group first reported a position in Johnson & Johnson in Q1 2024 and has held it in 7 quarters since.
2,221 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BayBridge Capital Group's 13F filing for Q2 2026, filed 14 Jul 2026.